Arrazola Pilar, Fernández Prada María, Gil Ángel, Gómez Rial José, Hernán Cristina, Menéndez Rosario, Trilla Antoni, Ortiz de Lejarazu Raúl
Servicio de Medicina Preventiva, Hospital Universitario 12 de Octubre, Madrid, Spain.
Servicio Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Asturias, Spain.
Enferm Infecc Microbiol Clin. 2025 Jan;43(1):36-46. doi: 10.1016/j.eimc.2024.08.012.
Despite high initial vaccination rates, Spain's current COVID-19 vaccination coverage in recommended groups does not meet WHO targets. For the upcoming season, challenges include revising vaccination age, updating risk groups, and unifying criteria with flu vaccine co-administration. European Commission's advance purchase agreements limit access to certain vaccines, and the need for vaccines effective against current variants adds administrative complexities. Spain's COVID-19 vaccination recommendations should adapt to these specific circumstances. Using vaccines effective against predominant variants with appropriate response duration is crucial to protect at-risk populations. Enhancing training and health education campaigns for health professionals and the general public, alongside utilizing tools to simplify vaccination recommendations, can promote higher vaccination rates in Spain. Addressing these challenges is essential to ensure adequate protection and improve vaccination coverage, ultimately achieving better public health outcomes in the face of evolving COVID-19 threats.
尽管初期疫苗接种率很高，但西班牙目前在推荐人群中的新冠疫苗接种覆盖率未达到世界卫生组织的目标。对于即将到来的季节，挑战包括调整疫苗接种年龄、更新风险群体以及统一流感疫苗联合接种标准。欧盟委员会的预购协议限制了某些疫苗的获取，并且需要有效对抗当前变种的疫苗增加了管理复杂性。西班牙的新冠疫苗接种建议应适应这些具体情况。使用对主要变种有效且具有适当反应持续时间的疫苗对于保护高危人群至关重要。加强针对卫生专业人员和公众的培训及健康教育活动，同时利用工具简化疫苗接种建议，可提高西班牙的疫苗接种率。应对这些挑战对于确保充分保护和提高疫苗接种覆盖率至关重要，最终在不断演变的新冠威胁面前实现更好的公共卫生成果。
